Immunohistochemistry in the era of personalised medicine
| Data(s) |
01/01/2013
|
|---|---|
| Resumo |
Immunohistochemistry (IHC) plays a central role in the histopathological classification of diseases, including cancer. More recently, the importance of immunohistochemical staining is increasing. IHC usage in diagnostics is invaluable; however, the genetic and therapeutic significance of biomarker immunostaining has become equally relevant. |
| Identificador | |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
McCourt , C M , Boyle , D , James , J & Salto-Tellez , M 2013 , ' Immunohistochemistry in the era of personalised medicine ' Journal of Clinical Pathology , vol 66 , no. 1 , pp. 58-61 . DOI: 10.1136/jclinpath-2012-201140 |
| Palavras-Chave | #Antineoplastic Agents #Pathology, Molecular #Receptor, erbB-2 #Humans #Breast Neoplasms #Receptors, Steroid #Pathology, Surgical #Antibodies, Monoclonal #Laboratories, Hospital #Individualized Medicine #Lung Neoplasms #Tumor Markers, Biological #Carcinoma, Non-Small-Cell Lung #Immunohistochemistry #Female #/dk/atira/pure/subjectarea/asjc/2700/2734 #Pathology and Forensic Medicine |
| Tipo |
article |
